Cypress Capital Management Cut Cvs Health (CVS) Holding by $710,208; Share Value Declined; Myr Group (Myrg) (MYRG) Holder Corbyn Investment Management Lowered Holding

April 21, 2018 - By Richard Conner

CVS Health Corporation (NYSE:CVS) Logo

Corbyn Investment Management Inc decreased its stake in Myr Group Inc. (Myrg) (MYRG) by 15.4% based on its latest 2017Q4 regulatory filing with the SEC. Corbyn Investment Management Inc sold 50,115 shares as the company’s stock declined 14.11% with the market. The institutional investor held 275,287 shares of the basic industries company at the end of 2017Q4, valued at $9.84 million, down from 325,402 at the end of the previous reported quarter. Corbyn Investment Management Inc who had been investing in Myr Group Inc. (Myrg) for a number of months, seems to be less bullish one the $507.53 million market cap company. The stock decreased 1.00% or $0.31 during the last trading session, reaching $30.82. About 54,984 shares traded. MYR Group Inc. (NASDAQ:MYRG) has declined 22.82% since April 21, 2017 and is downtrending. It has underperformed by 34.37% the S&P500.

Cypress Capital Management Llc decreased its stake in Cvs Health Corporation (CVS) by 68.62% based on its latest 2017Q4 regulatory filing with the SEC. Cypress Capital Management Llc sold 9,864 shares as the company’s stock declined 17.45% with the market. The institutional investor held 4,510 shares of the medical and nursing services company at the end of 2017Q4, valued at $327,000, down from 14,374 at the end of the previous reported quarter. Cypress Capital Management Llc who had been investing in Cvs Health Corporation for a number of months, seems to be less bullish one the $66.20B market cap company. The stock decreased 0.37% or $0.24 during the last trading session, reaching $65.12. About 6.17M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 21, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Among 10 analysts covering MYR Group (NASDAQ:MYRG), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 30% are positive. MYR Group had 31 analyst reports since August 11, 2015 according to SRatingsIntel. As per Wednesday, January 3, the company rating was maintained by Robert W. Baird. Maxim Group maintained the shares of MYRG in report on Friday, August 5 with “Buy” rating. Canaccord Genuity maintained it with “Buy” rating and $42.0 target in Thursday, March 8 report. The rating was maintained by Stifel Nicolaus on Wednesday, March 28 with “Hold”. FBR Capital maintained the shares of MYRG in report on Tuesday, March 8 with “Market Perform” rating. On Friday, November 3 the stock rating was maintained by Robert W. Baird with “Outperform”. The company was maintained on Friday, August 18 by FBR Capital. The stock has “Neutral” rating by Robert W. Baird on Friday, August 12. Robert W. Baird upgraded the shares of MYRG in report on Friday, May 5 to “Outperform” rating. FBR Capital maintained the stock with “Mkt Perform” rating in Friday, November 6 report.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.42, from 1.23 in 2017Q3. It fall, as 17 investors sold MYRG shares while 50 reduced holdings. 18 funds opened positions while 36 raised stakes. 14.13 million shares or 3.76% more from 13.62 million shares in 2017Q3 were reported. Commercial Bank Of Montreal Can reported 830 shares or 0% of all its holdings. Arizona State Retirement System, Arizona-based fund reported 27,668 shares. The New York-based Mufg Americas Corp has invested 0% in MYR Group Inc. (NASDAQ:MYRG). National Bank Of America De holds 0% or 66,014 shares in its portfolio. Assetmark stated it has 0% in MYR Group Inc. (NASDAQ:MYRG). Swiss Bancorporation reported 0% in MYR Group Inc. (NASDAQ:MYRG). Rice Hall James And Assocs Limited Liability Com has invested 0.07% in MYR Group Inc. (NASDAQ:MYRG). Moreover, Oppenheimer Com has 0.03% invested in MYR Group Inc. (NASDAQ:MYRG). Los Angeles Cap And Equity Rech holds 49,957 shares or 0.01% of its portfolio. Qs Limited Liability Company holds 0.02% or 50,888 shares. Corbyn Invest Mngmt Md reported 275,287 shares or 3.3% of all its holdings. Citadel Advsr Lc reported 31,096 shares. Inv Counselors Of Maryland Lc reported 1.17% in MYR Group Inc. (NASDAQ:MYRG). Texas Permanent School Fund owns 11,128 shares or 0% of their US portfolio. Keybank National Association Oh holds 0% or 19,500 shares.

Since March 16, 2018, it had 0 insider buys, and 2 insider sales for $748,904 activity.

Analysts await MYR Group Inc. (NASDAQ:MYRG) to report earnings on May, 2. They expect $0.17 EPS, up 142.86% or $0.10 from last year’s $0.07 per share. MYRG’s profit will be $2.80 million for 45.32 P/E if the $0.17 EPS becomes a reality. After $0.35 actual EPS reported by MYR Group Inc. for the previous quarter, Wall Street now forecasts -51.43% negative EPS growth.

Corbyn Investment Management Inc, which manages about $1.38B and $298.04M US Long portfolio, upped its stake in Conduent Inc. (Cndt) by 347,373 shares to 793,985 shares, valued at $12.83M in 2017Q4, according to the filing.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It fall, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Field & Main Commercial Bank invested in 0.32% or 4,651 shares. First Pacific Advsrs Ltd owns 61,560 shares for 0.03% of their portfolio. 7,817 are held by Wms Partners Ltd Liability Co. Moreover, Factory Mutual Insurance has 0.97% invested in CVS Health Corporation (NYSE:CVS) for 1.28M shares. Renaissance Inv Gru Lc, Massachusetts-based fund reported 4,050 shares. Kornitzer Ks, Kansas-based fund reported 37,385 shares. Tru Department Mb Fin State Bank N A has 0.08% invested in CVS Health Corporation (NYSE:CVS) for 10,873 shares. Girard accumulated 41,646 shares. Parametric Portfolio Associates Lc has invested 0.26% in CVS Health Corporation (NYSE:CVS). New York-based Wg Shaheen And Associate Dba Whitney And has invested 0.58% in CVS Health Corporation (NYSE:CVS). Moreover, Jpmorgan Chase & has 0.13% invested in CVS Health Corporation (NYSE:CVS). Canada Pension Plan Invest Board holds 1.29 million shares. Menta Cap Limited Liability Corporation reported 0.13% of its portfolio in CVS Health Corporation (NYSE:CVS). Karpas Strategies Limited Com accumulated 0.5% or 16,148 shares. Whalerock Point Ptnrs reported 0.64% of its portfolio in CVS Health Corporation (NYSE:CVS).

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. Jefferies downgraded CVS Health Corporation (NYSE:CVS) on Monday, December 12 to “Hold” rating. The stock has “Buy” rating by Tigress Financial on Tuesday, December 26. As per Tuesday, February 13, the company rating was maintained by Citigroup. On Friday, June 9 the stock rating was maintained by Jefferies with “Hold”. Citigroup maintained it with “Neutral” rating and $115 target in Monday, May 9 report. S&P Research maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 2. S&P Research has “Strong Buy” rating and $112 target. The firm has “Buy” rating given on Thursday, January 4 by Raymond James. The firm has “Hold” rating by Wolfe Research given on Wednesday, August 16. The firm has “Neutral” rating given on Monday, February 6 by Atlantic Securities. The firm has “Neutral” rating by Citigroup given on Monday, November 13.

Cypress Capital Management Llc, which manages about $611.62M and $520.75 million US Long portfolio, upped its stake in Exxon Mobil Corporation (NYSE:XOM) by 23,025 shares to 127,775 shares, valued at $10.69M in 2017Q4, according to the filing. It also increased its holding in Cisco Systems Inc (NASDAQ:CSCO) by 12,525 shares in the quarter, for a total of 381,580 shares, and has risen its stake in Union Pacific Corp (NYSE:UNP).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.63 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Since February 16, 2018, it had 0 insider buys, and 1 sale for $1.42 million activity.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts